Works matching IS 13518216 AND DT 2008 AND VI 14 AND IP 2

Results: 31

Single 270 μg kg−1-dose rFVIIa vs. standard 90 μg kg−1-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 287, doi. 10.1111/j.1365-2516.2007.01601.x

By:

Young, G.;
Shafer, F. E.;
Rojas, P.;
Seremetis, S.

Publication type:

Article

Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 303, doi. 10.1111/j.1365-2516.2007.01602.x

By:

Doria, A. S.;
Lundin, B.;
Miller, S.;
Kilcoyne, R.;
Dunn, A.;
Thomas, S.;
Rivard, G.;
Moineddin, R.;
BabynABYN, P. S.

Publication type:

Article

Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 260, doi. 10.1111/j.1365-2516.2007.01605.x

By:

Neunert, C. E.;
Miller, K. L.;
Journeycake, J. M.;
Buchanan, G. R.

Publication type:

Article

Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 323, doi. 10.1111/j.1365-2516.2007.01612.x

By:

Girolami, A.;
Ruzzin, E.;
Tezza, F.;
Scandellari, R.;
Scapin, M.;
Scarparo, P.

Publication type:

Article

Posturographic analysis of balance control in patients with haemophilic arthropathy.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 329, doi. 10.1111/j.1365-2516.2007.01613.x

By:

Gallach, J. E.;
Querol, F.;
González, L. M.;
Pardo, A.;
Aznar, J. A.

Publication type:

Article

Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines.

Published in:

2008

By:

Walsh, C. E.

Publication type:

Letter

Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B.

Published in:

2008

By:

Walker, J. A.;
Dixon, N.;
Gururangan, S.;
Thornburg, C.

Publication type:

Letter

Efficacy of factor VIII/von Willebrand factor concentrate Alphanate® in preventing excessive bleeding during surgery in subjects with von Willebrand disease.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 271, doi. 10.1111/j.1365-2516.2007.01616.x

By:

Rivard, G. E.;
Aledort, L.

Publication type:

Article

Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 233, doi. 10.1111/j.1365-2516.2007.01617.x

By:

Obergfell, A.;
Auvinen, M.-K.;
Mathew, P.

Publication type:

Article

Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 355, doi. 10.1111/j.1365-2516.2007.01618.x

By:

Pavlova, A.;
Diaz-Lacava, A.;
Zeitler, H.;
Satoguina, J.;
Niemann, B.;
Krause, M.;
Scharrer, I.;
Hoerauf, A.;
Wienker, T.;
Oldenburg, J.

Publication type:

Article

One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors.

Published in:

2008

By:

Sartori, R.;
Bisson, R.;
Baars, G. W.;
Petris, U.;
Radossi, P.;
Risato, R.;
Tassinari, C.;
Tagariello, G.

Publication type:

Letter

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 295, doi. 10.1111/j.1365-2516.2007.01620.x

By:

Greninger, D. A.;
Saint-Remy, J. M.;
Jacquemin, M.;
Benhida, A.;
DiMichele, D. M.

Publication type:

Article

Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 315, doi. 10.1111/j.1365-2516.2007.01621.x

By:

Unuvar, A.;
Kavakli, K.;
Baytan, B.;
Kazanci, E.;
Sayli, T.;
Oren, H.;
Celkan, T.;
Gursel, T.

Publication type:

Article

Abstracts of 10th WFH Musculoskeletal Congress.

Published in:: 2008
Publication type:: Abstract

A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 343, doi. 10.1111/j.1365-2516.2007.01623.x

By:

Tagliaferri, A.;
Rivolta, G. F.;
Biasoli, C.;
Valdré, L.;
Rodorigo, G.;
D'Incá, M.;
Miratelli, S.;
Albertini, P.;
Vincenzi, D.;
Arbasi, M. C.;
Marietta, M.;
Pattacini, C.

Publication type:

Article

European principles of haemophilia care.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 361, doi. 10.1111/j.1365-2516.2007.01625.x

By:

Colvin, B. T.;
Astermark, J.;
Fischer, K.;
Gringeri, A.;
Lassila, R.;
Schramm, W.;
Thomas, A.;
Ingerslev, J.

Publication type:

Article

Spontaneous intramural haematoma of the sigmoid colon causing acute intestinal obstruction in a haemophiliac: report of a case.

Published in:

2008

By:

Jarry, J.;
Biscay, D.;
Lepront, D.;
Rullier, A.;
Midy, D.

Publication type:

Letter

Medullary haemorrhage of the femur as presenting sign of haemophilia in a 22-month-old boy.

Published in:

2008

By:

Gahr, N.;
Zeiger, B.;
Hainmann, I.;
Uhl, M.

Publication type:

Letter

Some recent developments regarding arthropathy and inhibitors in haemophilia.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 242, doi. 10.1111/j.1365-2516.2007.01632.x

By:

Rodriguez-Merchan, E. C.

Publication type:

Article

Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 336, doi. 10.1111/j.1365-2516.2007.01633.x

By:

Maor, Y.;
Schapiro, J. M.;
Bashari, D.;
Lurie, Y.;
Safadi, R.;
Segol, O.;
Paritsky, M.;
Rachlis, Z.;
Avidan, B.;
Bar-Meir, S.;
Martinowitz, U.

Publication type:

Article

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 281, doi. 10.1111/j.1365-2516.2007.01634.x

By:

Rubinger, M.;
Lillicrap, D.;
Rivard, G. E.;
Teitel, J.;
Carcao, M.;
Hensman, C.;
Walker, I.

Publication type:

Article

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

Published in:

2008

By:

Economou, M.;
Teli, A.;
Tzantzaroudi, A.;
Tsatra, I.;
Zavitsanakis, A.;
Athanassiou-Metaxa, M.

Publication type:

Letter

In vivo models of haemophilia – status on current knowledge of clinical phenotypes and therapeutic interventions.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 248, doi. 10.1111/j.1365-2516.2007.01636.x

By:

Øvlisen, K.;
Kristensen, A. T.;
Tranholm, M.

Publication type:

Article

Multiple substitutions at single site: interpreting the effect of Asn92 mutations in human coagulation factor IX.

Published in:

2008

By:

Sharma, A.;
Chavali, S.;
Mahajan, A.;
Biswas, P.;
Bharadwaj, D.

Publication type:

Letter

Value added: increasing the power to assess treatment outcome in joint haemorrhages.

Published in:

Haemophilia, 2008, v. 14, n. 2, p. 276, doi. 10.1111/j.1365-2516.2007.01638.x

By:

Donfield, S. M.;
Astermark, J.;
Lail, A. E.;
Gilbert, S. A.;
Berntorp, E.

Publication type:

Article

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect.

Published in:

2008

By:

Winter, P. C.;
Egan, H.;
Mcnulty, O.;
Jones, F. G. C.;
O'Donnell, J.;
Jenkins, P. V.

Publication type:

Letter

Quality and easy availability of medical support overwhelmingly determines the attitude and belief towards genetic testing in haemophilia.

Published in:

2008

By:

Ghosh, K.;
Shelly, S.

Publication type:

Letter

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Published in:

2008

By:

Nichols, W. L.;
Hultin, M. B.;
James, A. H.;
Manco-Johnson, M. J.;
Montgomery, R. R.;
Ortel, T. L.;
Rick, M. E.;
Sadler, J. E.;
Weinstein, M.;
Yawn, B. P.

Publication type:

Other

Management of haemophilia in three premature infants.

Published in:

2008

By:

Kraft, K. E.;
Verlaak, R.;
Van Heijst, A. F. J.;
Nováková, I.;
Brons, P. P. T.

Publication type:

Letter

Erratum.

Published in:: 2008
Publication type:: Correction Notice

Erratum.

Published in:: 2008
Publication type:: Correction Notice

Works matching IS 13518216 AND DT 2008 AND VI 14 AND IP 2

Single 270 μg kg<sup>−1</sup>-dose rFVIIa vs. standard 90 μg kg<sup>−1</sup>-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.

Reliability and construct validity of the compatible MRI scoring system for evaluation of elbows in haemophilic children.

Implantable central venous access device procedures in haemophilia patients without an inhibitor: systematic review of the literature and institutional experience.

Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.

Posturographic analysis of balance control in patients with haemophilic arthropathy.

Prophylaxis for adults with severe haemophilia: a compelling need for evidence-based guidelines.

Perioperative factor IX replacement for surgical resection of a suprasellar astrocytoma in a child with severe haemophilia B.

Efficacy of factor VIII/von Willebrand factor concentrate Alphanate<sup>®</sup> in preventing excessive bleeding during surgery in subjects with von Willebrand disease.

Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.

Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls.

One-stage replacement of infected knee prosthesis in a patient with haemophilia A and high titre of inhibitors.

The use of factor VIII/von Willebrand factor concentrate for immune tolerance induction in haemophilia A patients with high-titre inhibitors: association of clinical outcome with inhibitor epitope profile.

Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.

Abstracts of 10<sup>th</sup> WFH Musculoskeletal Congress.

A web-based registry of inherited bleeding disorders in the region of Emilia-Romagna: results at three and a half years.

European principles of haemophilia care.

Spontaneous intramural haematoma of the sigmoid colon causing acute intestinal obstruction in a haemophiliac: report of a case.

Medullary haemorrhage of the femur as presenting sign of haemophilia in a 22-month-old boy.

Some recent developments regarding arthropathy and inhibitors in haemophilia.

Treatment of hepatitis C in patients with haemophilia – the Israeli National Hemophilia Center experience.

A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose.

Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.

In vivo models of haemophilia – status on current knowledge of clinical phenotypes and therapeutic interventions.

Multiple substitutions at single site: interpreting the effect of Asn92 mutations in human coagulation factor IX.

Value added: increasing the power to assess treatment outcome in joint haemorrhages.

A recurrent F8 mutation in Irish haemophilia A patients: evidence for a founder effect.

Quality and easy availability of medical support overwhelmingly determines the attitude and belief towards genetic testing in haemophilia.

von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Management of haemophilia in three premature infants.

Erratum.

Erratum.